IHS Chemical Week

Archives :: Chem Ideas :: Girish Malhotra

Displaying 1 - 20 of 44 stories.
October 25, 2012
Affordability of HIV/AIDS drugs is critical for the well-being and survival of patients especially in underdeveloped countries. Companies have done an excellent job of inventing the...
http://www.chemweek.com/chem_ideas/Girish-Malhotra/Improving-global-affordability-of-HIVAIDS-drugs-through-technology-innovation_47109.html
October 8, 2012
In the last thirty-five years about 351,000 US patents were classified in 424 and 514 class categories, i.e. they are drugs-related. This translates to about 10,000 patents per year. I...
http://www.chemweek.com/chem_ideas/Girish-Malhotra/Patents-Should-we-change-our-intellectual-property-modelstrategies_46799.html
August 7, 2012
The answer to the question is: It depends. This are not the answer one would expect from anyone who is a proponent of continuous processing. Indeed, “it depends” needs...
http://www.chemweek.com/chem_ideas/Girish-Malhotra/Is-Continuous-Processing-in-Pharmas-Future_45489.html
June 12, 2012
Reading two recent articles in Organic Process Research & Development magazine had me wondering about my chemistry and chemical engineering education and practices. They created a...
http://www.chemweek.com/chem_ideas/Girish-Malhotra/Is-the-New-Terminology-Going-to-Make-the-Pharmaceutical-Processes-Evironmentally-Friendly-and-Economic_44108.html
May 29, 2012
Quality by Design, or QbD, is targeted at having a robust and repeatable process which produces quality product without rework or re-testing) is financially important for the pharmaceutical industry and highly beneficial for the consumers; as it will ensure quality all the time, and potentially alleviate shortages and lower costs. In order for QbD to become part of the pharma landscape C and E levels of the companies need to have a very clear understanding of cost of regulatory compliance and financial benefits of QbD. Even with the understanding, timely implementation will need considerable cajoling within each company. I am not being opportunistic or pessimistic but being realistic....
http://www.chemweek.com/chem_ideas/Girish-Malhotra/Financial-Justification-for-QbD-and-Cost-of-Regulation-Compliance_43733.html
April 19, 2012
The answer to the question of whether there could be a revolution to bring about Quality by Design (QbD) in pharmaceutical manufacturing, unequivocally, is yes. But we need some...
http://www.chemweek.com/chem_ideas/Girish-Malhotra/Can-the-Combination-of-Creative-Destruction-and-Steve-Jobs-Traits-Lead-to-a-Pharma-QbD-Spring_42714.html
March 13, 2012
by Girish Malhotra, president of Epcot International (Pepper Pike, OH) During my career I have been involved in process simplification and cost reduction of different chemistries...
http://www.chemweek.com/chem_ideas/Girish-Malhotra/Neglected-Tropical-Disease-Drugs-What-are-they-Telling-Us-About-Innovation_41922.html
December 14, 2011
The spread of infectious diseases such as HIV/AIDS, malaria, schistosomiasis, and tuberculosis are a cause for global concern. Pharmaceutical companies have developed - and continue to...
http://www.chemweek.com/chem_ideas/Girish-Malhotra/Manufacturing-Opportunity-in-Drugs-for-Infectious-Diseases_39747.html
November 10, 2011
Little over a month ago Steve Jobs passed away. The tributes that have been forthcoming are breathtaking. This is in spite of his early career shortcomings. Besides creating amazing...
http://www.chemweek.com/chem_ideas/Girish-Malhotra/Does-the-Pharmaceutical-Industry-Need-a-Steve-Jobs_38976.html
October 18, 2011
Lately we have been reading and hearing shortages of many drugs. As a matter of fact the U.S. FDA on a routine basis publishes the list of drugs that are in short supply. Families and...
http://www.chemweek.com/chem_ideas/Girish-Malhotra/The-Cure-for-Drug-Shortages_38392.html
September 1, 2011
The U.S. FDA has created a fantastic opportunity for incorporating the best manufacturing technologies in the pharmaceutical hemisphere by charging fees to every generic company...
http://www.chemweek.com/chem_ideas/Girish-Malhotra/Generic-Drug-Fees-A-Fantastic-Oppprtunity_37313.html
August 2, 2011
A recent report by a committee comprised of Johnson & Johnson (J&J) board directors essentially gives J&J a clean bill of health for a series of incidents relating to...
http://www.chemweek.com/chem_ideas/Girish-Malhotra/Pharmaceutical-Quality-at-J-and-J-Goes-Under-the-Spotlight_36601.html
June 22, 2011
 In my recent trip to India, during my discussion with physicians about the various drugs that are used for HIV and tuberculosis, I was informed many times that patients (lower...
http://www.chemweek.com/chem_ideas/Girish-Malhotra/Drug-Prices-Food-v-Medicine-a-Difficult-Choice-for-Some-or-Many_35647.html
April 12, 2011
In my recent efforts to assist a client to find suppliers of certain product, I took the easy route i.e. using one of the search engines. The results were very interesting. Most of the...
http://www.chemweek.com/chem_ideas/Girish-Malhotra/Information-Challenges-for-Product-Process-Development-and-Process-Design-A-Reality-Check_34062.html
February 9, 2011
Patents are filed to preserve intellectual property for the duration of the patent life. This is the fundamental right of every inventor as they protect their invention from...
http://www.chemweek.com/chem_ideas/Girish-Malhotra/Are-Patents-a-Double-edged-Sword-Perspectives-Matter_32701.html
February 1, 2011
The environment for contract manufacturers is shifting, particularly in Asia where competition is having an impact on efficiencies of scale for contract research and manufacturing...
http://www.chemweek.com/chem_ideas/Girish-Malhotra/Inefficiency-in-Fine-Chemicals-Manufacture-Set-to-Grow_32217.html
January 12, 2011
Pharmaceutical companies including active pharmaceutical ingredient ( API) manufacturers have an uphill battle to achieve manufacturing perfection that will deliver quality product...
http://www.chemweek.com/chem_ideas/Girish-Malhotra/Pharmaceutical-Companies-Can-Innovate-if-they-Want_30290.html
October 6, 2010
Rules are generally created to be followed. They maintain discipline. However, to innovate many times they are broken intentionally or unintentionally. Such forays lead to the creation...
http://www.chemweek.com/chem_ideas/Girish-Malhotra/Are-FDA-Rules-a-Constraint-to-Innovation-Competition-and-a-Cause-of-Bad-Drugs_30012.html
September 7, 2010
Globally, Johnson & Johnson is known for its integrity and product quality. A few years ago they handled the Tylenol situation extremely well and were commended for it. It is...
http://www.chemweek.com/chem_ideas/Girish-Malhotra/Fundamentals-are-Important-at-Johnson-and-Johnson-and-Every-Business_29283.html
August 25, 2010
A ‘square plug in a round hole’ is a statement about situations that do not fit in normal life but under the right circumstances we can live with them. If this happens in a...
http://www.chemweek.com/chem_ideas/Girish-Malhotra/Square-Plug-in-a-Round-Hole-Does-this-Scenario-Exist-in-Pharmaceuticals_29015.html
Pages:  [1] 2 3 Next »










 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa